SCHEMBL11250263

SCHEMBL11250263

CCOC(=O)c1ccc(NCc2ccc(Cl)cc2)cc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.57
KCNQ3 O43525 1/20 0.50
KCNQ2 O43526 1/20 0.50
KCNQ4 P56696 1/20 0.50
KCNQ5 Q9NR82 1/20 0.50
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
P2RX3 P56373 3/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
EGFR P00533 1/20 0.46
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 1/20 0.44
HDAC1 Q13547 1/20 0.44
FFAR1 O14842 1/20 0.44
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992264 0.80 MAPK1 (0.51) NPC1KMT2AMAPK1CYP4F2CYP4A11
SCHEMBL11238983 0.79 MAPT (0.71) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL2773071 0.78 PPARA (0.59) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL11249609 0.76 PLK1 (0.46) ALDH1A1L3MBTL1SMN1; SMN2EGFRMAPK1
SCHEMBL11251685 0.76 PLK1 (0.46) ALDH1A1L3MBTL1SMN1; SMN2EGFRMAPK1
SCHEMBL2186694 0.76 EGFR (0.50) MAPTKCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL11695717 0.75 TSHR (0.52) ALDH1A1NPC1L3MBTL1GAAKMT2A
SCHEMBL16318414 0.75 NPC1 (0.56) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL10771374 0.74 MAPT (0.62) MAPTALDH1A1RAB9AL3MBTL1GAA
SCHEMBL25263361 0.74 MAPT (0.61) MAPTALDH1A1RAB9AGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4333940-A Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development AMERICAN CYANAMID COMPANY (US) 1982-06-08 US disclosed
US-4243609-A ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1981-01-06 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed